Reply To: Traders Market Weekly: Eyes Up on Retail and Inflation

#36547
Truman
Participant

Peloton (PTON 10.21, -3.92): -27.7% after missing EPS estimates and guiding fiscal Q4 revenue below consensus.
Upstart (UPST 35.80, -41.33): -53.6% after guiding Q2 revenue below consensus and lowering its FY22 revenue outlook. Upstart beat top and bottom-line estimates.
Novavax (NVAX 41.16, -12.10): -22.7% after missing revenue estimates.
Biohaven Pharma (BHVN 141.95, +58.81): +70.7% after agreeing to be acquired by Pfizer (PFE 48.16, -0.48, -1.0%) for $11.6 billion in cash. BHVN beat top and bottom-line estimates.